Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Albireo

Albireo
2008 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
ALBO STOCK SYMBOL
1 INVESTMENTS
$35.61 SHARE PRICE (As of Monday Closing)
Description

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of drug reformulation technology. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal.

Formerly Known As
Biodel
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 50 Milk Street
  • 16th floor
  • Boston, MA 02109
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Albireo’s full profile, request a free trial.

Albireo Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$19.10 - $38.69 $429M $35.98 -$5.12 52.2K 12M

Albireo Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 223,473 240,391 196,809 80,552
Revenue 2,108 12,740 1 0
EBITDA (55,995) (41,208) (24,207) (13,886)
Net Income (61,149) (46,111) (24,414) (13,755)
Total Assets 172,978 185,466 73,224 28,869
Total Debt 3,075
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Albireo Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Albireo‘s full profile, request access.

Request full access to PitchBook

Albireo Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Acceleron Pharma Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
000000 000000000 Formerly Angel backed New York, NY 00 00.000 00000000 00.000
00000 Formerly VC-backed Dublin, Ireland 00000 00000 000000&0 00000
00000000 000000000 Corporate Backed or Acquired Cambridge, MA 000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Albireo Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 03-Nov-2016 000000000000000000 Pharmaceuticals 000000 000000
To view this company’s complete investment and acquisition history, request access »

Albireo Executive Team (16)

Name Title Board
Seat
Contact
Info
Ronald Cooper Board Member, President and Chief Executive Officer
Jan Mattsson Ph.D Chief Operating Officer & Co-Founder
Paresh Soni MD Consultant
Pete Zorn JD Chief Corporate Officer, Senior Vice President & General Counsel
Martha Carter Chief Regulatory Officer

8 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Albireo Board Members (10)

Name Representing Role Since Contact
Info
Davey Scoon Biodel Board Member 000 0000
David Chiswell Ph.D Self Chairman 000 0000
Elisabeth Bjork Self Board Member 000 0000
Julia Brown Albireo Board Member 000 0000
Michael Gutch Ph.D Self Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »